Europe's PRAC wants domperidone curbs

10 March 2014 - Deborah Wilkes

Archived

Safety concerns have prompted the Pharmacovigilance Risk Assessment Committee (PRAC) to recommend restrictions on the use of medicines containing domperidone throughout the European Union.

Click tags below for more information on topics:

FAMHP

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: